| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/12/2001 | WO1999052541A3 Artery- and vein-specific proteins and uses therefor |
| 07/12/2001 | US20010008025 Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/12/2001 | US20010007767 Genetic engineering |
| 07/12/2001 | US20010007659 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 07/12/2001 | US20010007658 Medium and matrix for long-term proliferation of cells |
| 07/12/2001 | DE19963859A1 Bi- oder Oligomer eines Di-, Tri-, Quattro- oder Pentamers von rekombinanten Fusionsproteinen Bi- or oligomer of a di-, tri-, Quattro or pentamer of recombinant fusion proteins |
| 07/12/2001 | DE19963126A1 Verfahren zur Herstellung von 6-O-alpha-D-Glucopyranosyl-D-sorbit A process for the preparation of 6-O-alpha-D-glucopyranosyl-D-sorbitol |
| 07/12/2001 | DE19962456A1 Preparing tissue implant, useful for in vitro testing of pharmaceuticals, by expressing liquid from a homogeneous suspension of cells and matrix components |
| 07/12/2001 | DE19962154A1 Krankhaft veränderte Herzmuskelzelle, ihre Herstellung und Verwendung Diseased heart muscle cell, their preparation and use |
| 07/12/2001 | CA2402131A1 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
| 07/12/2001 | CA2396798A1 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396399A1 Methods for protein transfer |
| 07/12/2001 | CA2396222A1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 07/12/2001 | CA2396210A1 Method for cloning animals with targetted genetic alterations by transfer_of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells |
| 07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | CA2395456A1 Hydrogels |
| 07/12/2001 | CA2395117A1 Spore-like cells and uses thereof |
| 07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | CA2329318A1 Transgenic animal model of basal cell carcinoma |
| 07/11/2001 | EP1114866A2 Plasmids for the production of transgenic plants that are modified in habit and yield |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114322A1 Tandem immuno-assay for cancer |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114172A1 Transfer method for specific cellular localisation of nucleic acids |
| 07/11/2001 | EP1114170A2 Maize replication protein a |
| 07/11/2001 | EP1114169A1 Methods for producing genetically modified plants, plant materials and plant products produced thereby |
| 07/11/2001 | EP1114168A2 Uracil permease from arabidopsis as herbicidal target gene |
| 07/11/2001 | EP1114167A1 Salicylic acid inducible genes and promoters from tobacco |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114164A1 Atp synthase subunit homolog |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114147A1 A 2,6-$g(b)-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME |
| 07/11/2001 | EP1114146A2 Human serine/threonine protein kinases |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114064A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase |
| 07/11/2001 | EP1114058A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
| 07/11/2001 | EP1113812A1 Method and compositions for preventing or reducing hiv infection by use of inhibitors for leucine aminopeptidase |
| 07/11/2001 | EP1113807A2 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 07/11/2001 | EP0973872B1 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0700434B1 Novel process and apparatus |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303436A Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303434A Genetic method for producing riboflavin |
| 07/11/2001 | CN1303432A Novel insecticidal toxins from i(xenorhabdus nematophilus) and nucleic acid sequences coding therefor |
| 07/11/2001 | CN1303430A FAP alpha specific antibody with improved producibility |
| 07/11/2001 | CN1303428A 人蛋白c多肽 Human protein peptide c |
| 07/11/2001 | CN1303425A PNS cell lines and methods of use therefor |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1302810A Method of extracting DNA from spermatophore of fish |
| 07/11/2001 | CN1302651A Oral immune using plant product containing hepatitis surface antigen |
| 07/11/2001 | CN1068381C Method of producing taxane-type diterpene |
| 07/10/2001 | US6258998 Method of cloning porcine animals |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258935 Amino acid sequence of lymphocyte specific interferon regulatory factor, a type of transcription factor; recombinant expression of this polypeptide |
| 07/10/2001 | US6258929 Amino acid sequence of protein which binds presenilin 1; alzheimer's disease |
| 07/10/2001 | US6258870 Gels for encapsulation of biological materials |
| 07/10/2001 | US6258778 Methods for accelerating bone and cartilage growth and repair |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258598 EBV-infected stomach cancer cell line |
| 07/10/2001 | US6258597 Stimulation of hematopoietic cells in vitro |
| 07/10/2001 | US6258595 Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258579 I-kappa-b kinase signalsome capable of specifically phosphorylating i-kappa-b-alpha and i-kappa-b-beta; antiinflammatory agents; anticarcinogenic agents; viricides; treatment of autoimmune and nervous system disorders |
| 07/10/2001 | US6258564 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method the hybirdomas and antigen proteins recognized by the antibodies |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/10/2001 | US6258547 Nucleic acid encoding amp-activated protein kinase |
| 07/10/2001 | US6258529 Nucleotide sequences coding antibody; for use in diagnosis and human therapy |
| 07/10/2001 | US6258527 Transformed mammalian cell containing gene encoding cd4, construct encoding a reporter gene under control of human immunodeficiency virus long terminal repeat, and vector encoding a human chemokine receptor; analysis; drug screening |
| 07/10/2001 | US6258357 Extracting allogeneic human donor blood aliquot; separating t-cells; oxidatingstressing to reduce cytokines; administering to patient undergoing bone marrow transplant |
| 07/10/2001 | US6258354 Method for homing hematopoietic stem cells to bone marrow stromal cells |
| 07/10/2001 | US6258353 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 07/10/2001 | CA2295633A1 Formulation of embryo culture media i & ii (ecm i & ii) for optimal bovine embryo development |
| 07/10/2001 | CA2214629C Receptor activation by gas6 |
| 07/10/2001 | CA2089395C Monoclonal antibodies for detecting water treatment polymers |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2032505C Coat transmembrane glycoprotein antigens of a hiv-2 type human retrovirus and antigens sharing immunological similarities |
| 07/05/2001 | WO2001048470A1 The manufacture of improved support matrices |
| 07/05/2001 | WO2001048240A2 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease |
| 07/05/2001 | WO2001048215A1 RICE-ORIGIN GIBBERELLIN 2β-HYDROXYLASE GENES AND UTILIZATION THEREOF |
| 07/05/2001 | WO2001048214A2 METHOD FOR PRODUCING 6-0-α-D-GLUCOPYRANOSYL-D-SORBITE |
| 07/05/2001 | WO2001048209A2 Genes identified as required for proliferation of e. coli |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |